Oncobiologics' Series A - II Round

Oncobiologics raised a round of funding on September 29, 2015. Investors include Sabby Capital.

Oncobiologics is a privately-held biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics. It is advancing its pipeline of 11 biosimilar product…

Articles about Oncobiologics' Series A - II Round: